Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial

NCT00670787 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2011-03-07

No results posted yet for this study

Summary

The purpose of the study is to determine whether combination pill of losartan potassium and hydrochlorothiazide will improve medication compliance among patients with high blood pressure.

Conditions

Interventions

DRUG

Combination pill of losartan and hydrochlorothiazide

Combination pill of losartan potassium 50mg and hydrochlorothiazide 12.5mg in the morning

Sponsors & Collaborators

  • Kyushu University

    lead OTHER

Principal Investigators

  • Kiyoshi Matsumura, MD PhD · Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-11-30
Completion
2011-02-28

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00670787 on ClinicalTrials.gov